Kat Kolaski

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Systematic Review

Botulinum Toxin

Top Venues

Developmental medicine and child neurology

JBI evidence synthesis

This page only lists publications with an associated author ORCID identifier.

Publications

Kat Kolaski, Lynne Romeiser Logan, John P A Ioannidis
Principles for good scholarship in systematic reviews. Developmental medicine and child neurology (2023)
Kat Kolaski, Lynne Romeiser Logan, John P A Ioannidis
Guidance to best tools and practices for systematic reviews. JBI evidence synthesis (2023)
Kat Kolaski, Lynne Romeiser Logan, John P A Ioannidis
Guidance to Best Tools and Practices for Systematic Reviews. JBJS reviews 11 (6) (2023)
Kat Kolaski
Which antiepileptic drugs are safe and effective as monotherapy to treat focal and generalized seizures in adults and children? A Cochrane Review summary with commentary. Developmental medicine and child neurology (2022)
Kat Kolaski
Are anti-seizure medications effective and safe treatments for Lennox-Gastaut syndrome? A Cochrane Review summary with commentary. Developmental medicine and child neurology 64 (6) (2022)
Kat Kolaski
Is chloral hydrate effective and safe as a sedating agent for neurodiagnostic procedures in children? A Cochrane Review summary with commentary. Developmental medicine and child neurology 64 (8) (2022)
Lynne Romeiser Logan, Kat Kolaski
Guideline to improve physical function in cerebral palsy: too big to succeed. Developmental medicine and child neurology 64 (5) (2022)
Kat Kolaski, Lynne Romeiser Logan, Katherine D Goss, Charlene Butler
Quality appraisal of systematic reviews of interventions for children with cerebral palsy reveals critically low confidence. Developmental medicine and child neurology 63 (11) (2021)
Kat Kolaski
Botulinum toxin: did the black box warning change how we treat children with cerebral palsy? Developmental medicine and child neurology 60 (5) (2018)